Use of lipoxin compounds for inhibiting of TNF-(alfa) initiated neutrophil response

Details for Australian Patent Application No. 2007214312 (hide)

Owner The Brigham and Women's Hospital, Inc.

Inventors Serhan, Charles N.

Agent Watermark

Pub. Number AU-B-2007214312

Parent 2004222825

Filing date 30 August 2007

Wipo publication date 20 September 2007

Acceptance publication date 28 October 2010

International Classifications

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61K 31/202 (2006.01)

A61K 31/23 (2006.01)

A61K 31/232 (2006.01)

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/08 (2006.01) Drugs for dermatological disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

13 September 2007 Complete Application Filed

20 September 2007 Application Open to Public Inspection

  Published as AU-B-2007214312

28 October 2010 Application Accepted

  Published as AU-B-2007214312

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007214313-Computerized method for adherence to physical restriction in the construction of an ITE hearing aid

2007214311-Work Stand